Results 101 to 110 of about 6,588 (185)

FBXO7 ubiquitinates PRMT1 to suppress serine synthesis and tumor growth in hepatocellular carcinoma

open access: yesNature Communications
Cancer cells are often addicted to serine synthesis to support growth. How serine synthesis is regulated in cancer is not well understood. We recently demonstrated protein arginine methyltransferase 1 (PRMT1) is upregulated in hepatocellular carcinoma ...
Li Luo   +9 more
doaj   +1 more source

Non-canonical function of PHGDH promotes HCC metastasis by interacting with METTL3

open access: yesCellular Oncology
Phosphoglycerate dehydrogenase (PHGDH), a pivotal enzyme in serine synthesis, plays a key role in the malignant progression of tumors through both its metabolic activity and moonlight functions. This study aims to elucidate the non-canonical function of PHGDH in promoting hepatocellular carcinoma (HCC) metastasis through its interaction with ...
Cheng, Bin   +5 more
openaire   +3 more sources

ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesis

open access: yesCell Death and Disease
Argininosuccinate synthase (ASS1), a critical enzyme in the urea cycle, acts as a tumor suppressor in many cancers. To date, the anticancer mechanism of ASS1 has not been fully elucidated. Here, we found that phosphoglycerate dehydrogenase (PHGDH), a key
Wensong Luo   +14 more
doaj   +1 more source

Phosphoglycerate Dehydrogenase Overexpression Inhibits Ferroptosis to Repress Calcification of Human Coronary Artery Vascular Smooth Muscle Cells via the P53/SLC7A11 Pathway

open access: yesInternational Journal of General Medicine
Yuhai Zou,1,* Dongdong Li,1,* Ge Guan,1 Wenting Liu2 1Department of Cardiology, General Hospital of Southern Theatre Command of PLA, Guangzhou, 510010, People’s Republic of China; 2Department of Otorhinolaryngology, Guangzhou First People’s ...
Zou Y, Li D, Guan G, Liu W
doaj  

Mechanistic study of PHGDH enzyme inhibition : towards the development of new anticancer drugs

open access: yes, 2019
The selective targeting of metabolic differences that allow cancer cells to proliferate appears as a promising strategy to develop novel anticancer agents.
Spillier, Quentin
core  

Home - About - Disclaimer - Privacy